Cullinan Therapeutics (CGEM) Stock Chart & Stock Price History $7.64 -0.55 (-6.72%) Closing price 08/25/2025 04:00 PM EasternExtended Trading$7.64 0.00 (-0.07%) As of 08/25/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cullinan Therapeutics Stock Price Performance The Cullinan Therapeutics (CGEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 58.16%, with a year-to-date return of -37.27%. In the past month, the stock has decreased 6.60%, reflecting recent market activity. As of the latest close, Cullinan Therapeutics traded at $7.64 with a market cap of $451.30 million and volume of 220,874 shares. Receive CGEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.39%1 Month Performance-6.60%3 Month Performance-2.18%Year-To-Date Performance-37.27%1 Year Performance-58.16% CGEM Stock Chart for Tuesday, August, 26, 2025 CGEM Chart by TradingView Cullinan Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$8.19$7.64-6.72%$8.15$7.54220,874 shs$451.30 million08/22/2025$7.67$8.19+6.78%$8.32$7.76629,410 shs$483.78 million08/21/2025$7.47$7.67+2.68%$7.75$7.50296,078 shs$453.07 million08/20/2025$7.58$7.47-1.45%$7.63$7.44262,738 shs$441.28 million08/19/2025$7.95$7.58-4.65%$7.95$7.44299,733 shs$447.75 million08/18/2025$7.66$7.95+3.79%$8.08$7.64432,866 shs$469.61 million08/15/2025$7.58$7.66+1.06%$7.81$7.58379,391 shs$452.48 million08/14/2025$7.64$7.58-0.79%$7.65$7.35341,076 shs$447.78 million08/13/2025$7.27$7.64+5.09%$7.76$7.34365,458 shs$451.30 million08/12/2025$7.09$7.27+2.54%$7.40$7.09302,565 shs$429.44 million Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$7.30$7.09-2.88%$7.33$6.91411,050 shs$418.42 million08/08/2025$7.03$7.30+3.84%$7.57$6.89544,965 shs$430.77 million08/07/2025$7.88$7.03-10.79%$7.80$6.95486,561 shs$414.88 million08/06/2025$8.08$7.88-2.48%$8.01$7.75225,546 shs$465.00 million08/05/2025$7.94$8.08+1.76%$8.13$7.86229,744 shs$476.80 million08/04/2025$7.67$7.94+3.52%$8.00$7.52272,441 shs$468.58 million08/01/2025$7.77$7.67-1.29%$7.77$7.61259,804 shs$452.65 million07/31/2025$8.16$7.77-4.78%$8.15$7.75241,753 shs$458.51 million07/30/2025$8.34$8.16-2.16%$8.59$7.911.17 million shs$481.52 million07/29/2025$8.23$8.34+1.34%$8.41$8.19299,078 shs$492.19 million07/28/2025$8.18$8.23+0.61%$8.35$8.15182,993 shs$485.65 million07/25/2025$8.33$8.18-1.80%$8.29$8.07184,993 shs$482.70 million Related Companies BEAM Stock Price Chart DYN Stock Price Chart APGE Stock Price Chart TWST Stock Price Chart TVTX Stock Price Chart BHVN Stock Price Chart IMCR Stock Price Chart CDTX Stock Price Chart AUPH Stock Price Chart WVE Stock Price Chart Receive CGEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGEM) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access